SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of SELLAS Life Sciences Group Inc..
SELLAS Life Sciences Group Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of SELLAS Life Sciences Group Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of SELLAS Life Sciences Group Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of SELLAS Life Sciences Group Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of SELLAS Life Sciences Group Inc. and all latest updates of the company are provided.
The 2025 version of SELLAS Life Sciences Group Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 SELLAS Life Sciences Group Inc.- Key Facts
2.2 SELLAS Life Sciences Group Inc.- Geographic Locations
2.3 SELLAS Life Sciences Group Inc.- Subsidiaries and Affiliates
2.4 SELLAS Life Sciences Group Inc.- Business Divisions
2.5 SELLAS Life Sciences Group Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. SELLAS Life Sciences Group Inc. Strategic Analysis Review
3.1 SELLAS Life Sciences Group Inc.- Key Strategies
3.2 SELLAS Life Sciences Group Inc.- Company Outlook Statement
3.3 SELLAS Life Sciences Group Inc.- SWOT Analysis
3.3.1 SELLAS Life Sciences Group Inc.- Key Strengths
3.3.2 SELLAS Life Sciences Group Inc.- Key Weaknesses
3.3.3 SELLAS Life Sciences Group Inc.- Potential Opportunities
3.3.4 SELLAS Life Sciences Group Inc.- Potential Threats
3.4 SELLAS Life Sciences Group Inc.- Key Competitors
4. Business Description of the Company
4.1 SELLAS Life Sciences Group Inc.- Business Overview
4.2 SELLAS Life Sciences Group Inc.- Operations by Segment
5 Products and Services Details
5.1 SELLAS Life Sciences Group Inc.- Key Products
5.2 SELLAS Life Sciences Group Inc.- Key Service Areas
5.3 SELLAS Life Sciences Group Inc.- Key Brands
6 Company Developments
6.1 SELLAS Life Sciences Group Inc.- Company History
6.2 SELLAS Life Sciences Group Inc.- Latest Developments
7 Financial Analysis
7.1 SELLAS Life Sciences Group Inc.- Income Statements
7.2 SELLAS Life Sciences Group Inc.- Balance Sheet
7.3 SELLAS Life Sciences Group Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 SELLAS Life Sciences Group Inc.- Direct Competitors
8.2 SELLAS Life Sciences Group Inc.- Competitor Financial Ratios comparison
8.3 SELLAS Life Sciences Group Inc.- Competitor Stock Charts Comparison
8.4 SELLAS Life Sciences Group Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!